Yongjia Wang

Sep 24, 2024 | onlinelibrary.wiley.com | Pengyang Wang |Donghao Wu |Yongjia Wang |Zhiqiang Shen

CONFLICT OF INTEREST STATEMENT The authors declare no competing interests. Supporting Information Filename Description jpe14786-sup-0001-Supinfo.docxWord 2007 document , 4.1 MB Table Se1.1. The model fit with abundance data. Table Se1.2. The model fit with abundance data with inversing the path of RIFA to CNA (poor fit). Table Se1.3. The model fit with mound number data. Table Se1.4. The model fit with absence/presence data.

Jan 16, 2024 | kevinmd.com | Yongjia Wang |Jennifer Lycette |Michael Millenson |Robert Pearl

In 2020, the ICPerMed (International Consortium for Personalized Medicine) published a ten-year vision for how personalized medicine, a new form of medicine, has the potential to rebuild an equitable and accessible health care system by 2030. Precision or personalized medicines are drugs developed with genomic sequencing technologies, targeting the critical genes in specific types of cancer or genetic diseases.